Monday, 14 January 2019

New ALS drug slows disease progression in groundbreaking clinical trial

A new drug, known as CuATSM, has had promising results in treating ALS in a Phase ...

Motor neurone disease (MND), also known as amyotrophic lateral sclerosis (ALS), is a devastating disease that quickly kills the brain cells in charge of muscle control, usually claiming the lives of patients within a few years. But now a new drug developed by a team of Australian scientists has shown promise in a Phase 1 clinical trial, improving symptoms and slowing progression of the disease.

.. Continue Reading New ALS drug slows disease progression in groundbreaking clinical trial

Category: Medical

Tags:

from New Atlas (Gizmag) http://bit.ly/2MaM7wz

No comments:

Post a Comment